Ds. Kucukaksu et al., BENEFICIAL-EFFECTS OF PROSTACYCLIN ON PULMONARY-FUNCTION DURING HEPARIN REVERSAL WITH PROTAMINE, Vascular surgery, 27(4), 1993, pp. 264-267
This study was planned to show the beneficial effects of prostacyclin
(PGI2) on pulmonary function after heparin reversal with protamine. Tw
enty-eight patients entered the study. Half of these patients received
prostacyclin, whereas the other patients did not. N-acetyl glucosamin
idase (NAG) level was 37.6+/-4.7 pmoL/mL in the control group and 19.7
+/-3.8 pmoL/mL in the PGI2 group (p < 0.001) rive minutes after protam
ine administration. Leukotriene B4 (LTB4) level was 118+/-13.7 pmoL/mL
in the control group and 56+/-13.8 pmoL/mL in the PGI2 group (p < 0.0
01). Alveolar-arterial oxygen difference was 69+/-15 mmHg in the contr
ol group and 58+/-11 mmHg in the PGI2 group (p < 0.05). As a result of
this study it was concluded that PGI2 reduced the toxic manifestation
s of heparin-protamine complex and improved the pulmonary gas exchange
.